Antiviral Therapeutics Market Research(COCP mentioned)
Feb 20, 2021 15:41:52 GMT
icemandios and opkfrostfan like this
Post by c2crusher on Feb 20, 2021 15:41:52 GMT
Speculates the global antiviral market going from 56 billion to 81 billion in 5 years.
Includes ~150 million market cap company COCRYSTAL PHARMA.
(Also interesting that COCP only company listed in "All Caps.")
www.marketwatch.com/press-release/antiviral-therapeutics-market-research-report-by-drug-by-distribution---global-forecast-to-2025---cumulative-impact-of-covid-19-2021-02-18
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antiviral Therapeutics Market including Abbott Laboratories, AbbVie Inc., Atea Pharmaceuticals, Aurobindo Pharma Limited, Bristol-Myers Squibb Company, Cipla Inc., COCRYSTAL PHARMA, INC., Daiichi Sankyo Co. Ltd., Eli Lilly & Co., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline PLC, Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Merck & Co., Pfizer Inc., Sanofi S.A., Schering-Plough Corporation, Venatorx Pharmaceuticals, Inc., and Vienna BioCenter.
Includes ~150 million market cap company COCRYSTAL PHARMA.
(Also interesting that COCP only company listed in "All Caps.")
www.marketwatch.com/press-release/antiviral-therapeutics-market-research-report-by-drug-by-distribution---global-forecast-to-2025---cumulative-impact-of-covid-19-2021-02-18
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antiviral Therapeutics Market including Abbott Laboratories, AbbVie Inc., Atea Pharmaceuticals, Aurobindo Pharma Limited, Bristol-Myers Squibb Company, Cipla Inc., COCRYSTAL PHARMA, INC., Daiichi Sankyo Co. Ltd., Eli Lilly & Co., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline PLC, Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Merck & Co., Pfizer Inc., Sanofi S.A., Schering-Plough Corporation, Venatorx Pharmaceuticals, Inc., and Vienna BioCenter.